
Who Gets to Define a ‘Healthy’ Baby?
“Should human life be optimized?” asks the second installment in a new three-part series by the The New York Times titled “The Embryo Question.” It features Orchid, a cutting-edge technology company (based in the United States) that offers “polygenic risk …